Business

Development Agreement Signed

Development Agreement Signed.

articleRua Life Sciences PlcJune 19, 20184/company/rua-life-sciences-plc/news/development-agreement-signed
Development Agreement Signed

About this update from Rua Life Sciences Plc

[{"type":"text","content":"\n \nRNS Number : 8386R AorTech International PLC 19 June 2018  \n\n19 June 2018 \nAorTech International plc \n(\"AorTech\" or the \"Company\") \n  \nDevelopment Agreement signed with Vascular Flow Technologies Limited (\"VFT\")\n \nAorTech (AIM: AOR), the biomaterials and medical device IP company, is pleased to announce that it has signed a Development Agreement with VFT (the \"Agreement\") for the development of its synthetic heart valve project. The execution of the Agreement, details of which were contained in the Company's announcement of 21 May 2018, follows a period of Technology Transfer where a detailed review of AorTech's historic data, testing and designs was undertaken by the team at VFT.\n \nThe project to be undertaken involves detailed computational modelling and analysis of AorTech's heart valve leading to further design optimisation, manufacturing and testing with the objective of preparing a detailed data pack to justify first \"in man\" testing of this highly disruptive technology.\n \nBill Brown, Chairman of AorTech, said: \"In partnering with the team at VFT, AorTech now has access to Europe's leading experts in the combined field of medical imaging, guided Finite Element Analysis and Computational Fluid Dynamics. Combining the design history with this ground breaking imaging analysis should much improve the quality of the product design, reliability and performance.\"\nCraig Dunlop, General Manager and Director of VFT, said: \"The team at VFT has been very impressed with the quantity and quality of data that AorTech has been able to demonstrate to us. We are  very excited to be a key partner in the development of the next generation of prosthetic heart valves which should represent not only a step change in performance, but dramatically reduce the cost to manufacture these life enhancing devices.\"  \n  \nFor further information contact: \n  \nAorTech International plc                                            Tel: +44 (0)7730 718296  \nBill Brown, Chairman      &nbs...

More updates from Rua Life Sciences Plc